These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 21037224)

  • 61. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2.
    Gago-Dominguez M; Bell DA; Watson MA; Yuan JM; Castelao JE; Hein DW; Chan KK; Coetzee GA; Ross RK; Yu MC
    Carcinogenesis; 2003 Mar; 24(3):483-9. PubMed ID: 12663508
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.
    Gates MA; Tworoger SS; Terry KL; Titus-Ernstoff L; Rosner B; De Vivo I; Cramer DW; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2436-44. PubMed ID: 18768514
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
    Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
    van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
    Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
    Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
    Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis.
    Ambrosone CB; Kropp S; Yang J; Yao S; Shields PG; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):15-26. PubMed ID: 18187392
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
    Osawa Y; Osawa KK; Miyaishi A; Higuchi M; Tsutou A; Matsumura S; Tabuchi Y; Tsubota N; Takahashi J
    Asian Pac J Cancer Prev; 2007; 8(1):103-8. PubMed ID: 17477782
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
    Cascorbi I; Roots I; Brockmöller J
    Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [TBL] [Abstract][Full Text] [Related]  

  • 70. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
    Pesch B; Gawrych K; Rabstein S; Weiss T; Casjens S; Rihs HP; Ding H; Angerer J; Illig T; Klopp N; Bueno-de-Mesquita B; Ros MM; Kaaks R; Chang-Claude J; Roswall N; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Dossus L; Boeing H; Weikert S; Trichopoulos D; Palli D; Sieri S; Tumino R; Panico S; Quirós JR; González C; Sánchez MJ; Dorronsoro M; Navarro C; Barricarte A; Ljungberg B; Johansson M; Ulmert D; Ehrnström R; Khaw KT; Wareham N; Key TJ; Ferrari P; Romieu I; Riboli E; Brüning T; Vineis P
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2055-65. PubMed ID: 24092628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.
    Sanderson S; Salanti G; Higgins J
    Am J Epidemiol; 2007 Oct; 166(7):741-51. PubMed ID: 17675654
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors.
    Procopciuc LM; Osian G
    Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NAT2*5/*5 genotype (341T>C) is a potential risk factor for schistosomiasis-associated bladder cancer in Egyptians.
    El Desoky ES; AbdelSalam YM; Salama RH; El Akkad MA; Atanasova S; von Ahsen N; Armstrong VW; Oellerich M
    Ther Drug Monit; 2005 Jun; 27(3):297-304. PubMed ID: 15905799
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma.
    Hirvonen A; Pelin K; Tammilehto L; Karjalainen A; Mattson K; Linnainmaa K
    Cancer Res; 1995 Jul; 55(14):2981-3. PubMed ID: 7606714
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.
    Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluating interactions of polygenic risk scores and NAT2 genotypes with tobacco smoking in bladder cancer risk.
    Pradhan P; Jia G; Khankari NK; Zheng W
    Int J Cancer; 2024 Jan; 154(2):210-216. PubMed ID: 37728483
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population.
    Topinka J; Binková B; Mracková G; Stávková Z; Peterka V; Benes I; Dejmek J; Lenícek J; Pilcík T; Srám RJ
    Environ Mol Mutagen; 1997; 30(2):184-95. PubMed ID: 9329643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder.
    Kempkes M; Golka K; Reich S; Reckwitz T; Bolt HM
    Arch Toxicol; 1996; 71(1-2):123-6. PubMed ID: 9010594
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.